Login to Your Account

Investors from U.S. and Europe

Morphosys Gets $114M to Fund Antibody Programs, Acquisitions

By Cormac Sheridan
Staff Writer

Friday, September 20, 2013
Morphosys AG raised 84 million (US$114 million) in a private placement, adding another hefty chunk of change to what is already a robust balance sheet.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription